title: MYC/BCL2 double-expression vs. cell-of-origin classification in diffuse large B-cell lymphoma: do we need to know both?
authors.affiliation: a Department of Pathology , Massachusetts General Hospital , Boston , MA , USA ;
authors.forename: Aliyah R
authors.initials: AR
authors.lastname: Sohani
authors.affiliation: b Center for Lymphoma, Massachusetts General Hospital Cancer Center , Boston , MA , USA.
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Abramson
mesh_terms: D006801:Humans; D016393:Lymphoma, B-Cell; D016403:Lymphoma, Large B-Cell, Diffuse; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis; D016271:Proto-Oncogene Proteins c-myc
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc